MYCB1 Group B.V.

ALETTA

Downloadable software, namely, software for receiving, processing, transmitting and displaying medical data and data regarding the well being of patients; Downloadable computer software using artificial intelligence for receiving, processing, transmitting and displaying medical data and data regarding the well being of patients;The wording ALETTA has no meaning in a foreign language.;Platform as a service (PAAS) featuring computer software platforms for receiving, processing, transmitting and displaying medical data and data regarding the well being of patients; development of software; software as a service (SAAS) services featuring software for receiving, processing, transmitting and displaying medical data and data regarding the well being of patients; providing online non-downloadable artificial intelligence software for receiving, processing, transmitting and displaying medical data and data regarding the well being of patients;

MYCB1

The mark consists of the wording MYCB1 below a geometric design comprised of two triangles, two rectangles and one square.;Nutraceutical products for use as dietary supplements or for therapeutic purposes; Nutritional supplements; Dietetic foods adapted for medical use; Biotechnological preparations for medical use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, heart disease, cancer prevention and treatment, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders;Color is not claimed as a feature of the mark.;Biotechnological services, namely, research and consultancy in the field of biotechnology; Development of biotechnological products;